AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
58 hedge funds and large institutions have $79M invested in AVEO Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
Holders
58
Holding in Top 10
1
Calls
$3.34M
Puts
$657K
Top Buyers
| 1 | +$1.47M | |
| 2 | +$1.3M | |
| 3 | +$864K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$671K |
| 5 |
JGC
J. Goldman & Co
New York
|
+$499K |
Top Sellers
| 1 | -$7.04M | |
| 2 | -$1.36M | |
| 3 | -$1.19M | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$579K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$527K |